Infectious agents and neurodegeneration

Molecular Neurobiology

Volumn 46, Issue 3, 2012, Pages 614-638

  De Chiara, Giovanna ^a   Marcocci, Maria Elena ^b   Sgarbanti, Rossella ^c   Civitelli, Livia ^b   Ripoli, Cristian ^d   Piacentini, Roberto ^d   Garaci, Enrico ^e   Grassi, Claudio ^d   Palamara, Anna Teresa ^b,c  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c IRCCS SAN RAFFAELE PISANA   (Italy)

^d CATHOLIC UNIVERSITY   (Italy)

^e UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Alzheimer's disease; C. pneumoniae; HIV; HSV 1; Influenza virus; Neurodegeneration

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; ANTIRETROVIRUS AGENT; APOLIPOPROTEIN E; APOLIPOPROTEIN E4; BECLIN 1; BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; CARRIER PROTEIN; CASPASE 3; GLUTATHIONE; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 140; INFECTED CELL POLYPEPTIDE 34 5; INSULINASE; INTERLEUKIN 6; MEMBRANE METALLOENDOPEPTIDASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NECTIN 2; NEF PROTEIN; NERVE GROWTH FACTOR; NICASTRIN; POLYPEPTIDE; PROTEIN TOMM40; TRANSACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG; VPR PROTEIN; ZIDOVUDINE;

AGING; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; ARTICLE; AUTOPHAGY; BLOOD BRAIN BARRIER; CELL FUNCTION; CELL VIABILITY; CENTRAL NERVOUS SYSTEM INFECTION; CHLAMYDOPHILA PNEUMONIAE; CHRONIC DISEASE; COMORBIDITY; CORONARY ARTERY DISEASE; GENE STRUCTURE; HERPES SIMPLEX VIRUS 1; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED DEMENTIA; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLIPIDEMIA; IMMUNE RESPONSE; INFLAMMATION; INFLUENZA VIRUS; INSULIN RESISTANCE; LEWY BODY; METABOLIC DISORDER; NERVE CELL NECROSIS; NERVE DEGENERATION; NERVE FIBER TRANSPORT; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRION DISEASE; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN FOLDING; RISK FACTOR; SIMIAN IMMUNODEFICIENCY VIRUS; SYNAPSE; VIRUS GENOME; VIRUS REPLICATION; ANIMAL; BACTERIAL INFECTION; BIOLOGICAL MODEL; CENTRAL NERVOUS SYSTEM; MICROBIOLOGY; PATHOLOGY; REVIEW; VIROLOGY; VIRUS INFECTION;

ANIMALS; BACTERIAL INFECTIONS; CENTRAL NERVOUS SYSTEM; HUMANS; MODELS, BIOLOGICAL; NERVE DEGENERATION; OXIDATIVE STRESS; VIRUS DISEASES;

EID: 84880272117     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-012-8320-7     Document Type: Article

References (304)

1. Bowery NG, Bagetta G, Nisticó G et al (1992) Intrahippocampal tetanus toxin produces generalized convulsions and neurodegeneration in rats: antagonism by NMDA receptor blockers. Epilepsy Res Suppl 9:249-256
2. Mattson MP (2004) Infectious agents and age-related neurodegenerative disorders. Ageing Res Rev 3:105-120
3. Cermelli C, Vinceti M, Beretti F et al (2003) Risk of sporadic amyotrophic lateral sclerosis associated with seropositivity for herpesvirus and echovirus-7. Eur J Epidemiol 18:123-127
4. Ogata A, Tashiro K, Nukuzuma S et al (1997) A rat model of Parkinson's disease induced by Japanese encephalitis virus. J Neurovirol 3:141-147
5. Menninger KA (1919) Psychoses associated with influenza. Arch Neurol Psychiatr 2:291-337
6. Menninger KA (1926) Influenza and schizophrenia. An analysis of post-influenzal "dementia precox" as of 1918 and five years later. Am J Psychiatr 5:469-529
7. Takahashi M, Yamada T (1999) Viral etiology for Parkinson's disease - a possible role of influenza A virus infection. Jpn J Infect Dis 52:89-98
8. Balin BJ, Gerard HC, Arking EJ et al (1998) Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain. Med Microbiol Immunol (Berl) 187:23-42
9. Balin BJ, Appelt DM (2001) Role of infection in Alzheimer's disease. J Am Osteopath Assoc 101:S1-S6
10. Dobson CB, Itzhaki RF (1999) Herpes simplex virus type 1 and Alzheimer's disease. Neurobiol Aging 20:457-465
11. Jamieson GA, Maitland NJ, Craske J et al (1991) Detection of herpes simplex virus type 1 DNA sequences in normal and Alzheimer's disease brains using polymerase chain reaction. Biochem Soc Trans 19:122S
12. Itabashi S, Arai H, Matsui T et al (1997) Herpes simplex virus and risk of Alzheimer's disease. Lancet 349:1102
13. Mori I, Kimura Y, Naiki H et al (2004) Reactivation of HSV-1 in the brain of patients with familial Alzheimer's disease. J Med Virol 73:605-611
14. Wozniak MA, Shipley SJ, Combrinck M et al (2005) Productive herpes simplex virus in brain of elderly normal subjects and Alzheimer's disease patients. J Med Virol 75:300-306
15. Wozniak MA, Frost AL, Preston CM, Itzhaki RF (2011) Antivirals reduce the formation of key Alzheimer's disease molecules in cell cultures acutely infected with herpes simplex virus type 1. PLoS One 6:e25152
16. Ben Fredj N, Rotola A, Nefzi F et al (2011) Identification of human herpesviruses 1 to 8 in Tunisian multiple sclerosis patients and healthy blood donors. J Neurovirol. doi: 10.1007/s13365-011-0056-z
17. Giovannoni G, Cutter GR, Lunemann J et al (2006) Infectious causes of multiple sclerosis. Lancet Neurol 5:887-894
18. Giovannoni G, Ebers G (2007) Multiple sclerosis: the environment and causation. Curr Opin Neurol 20:261-268
19. Kurtzke JF (1993) Epidemiologic evidence for multiple sclerosis as an infection. Clin Microbiol Rev 6:382-427
20. Mancuso R, Delbue S, Borghi E et al (2007) Increased prevalence of Varicella zoster virus DNA in cerebrospinal fluid from patients with multiple sclerosis. J Med Virol 79:192-199
21. Salvetti M, Giovannoni G, Aloisi F (2009) Epstein-Barr virus and multiple sclerosis. Curr Opin Neurol 22:201-206
22. Serafini B, Rosicarelli B, Franciotta D et al (2007) Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J Exp Med 204:2899-2912
23. Zivadinov R, Nasuelli D, Tommasi MA et al (2006) Positivity of cytomegalovirus antibodies predicts a better clinical and radiological outcome in multiple sclerosis patients. Neurol Res 28:262-269
24. Ballatori N, Krance SM, Notenboom S et al (2009) Glutathione dysregulation and the etiology and progression of human diseases. Biol Chem 390:191-214
25. Govoni S, Amadio M, Battaini F, Pascale A (2010) Senescence of the brain: focus on cognitive kinases. Curr Pharm Des 16:660-671
26. McGavern DB, Kang SS (2011) Illuminating viral infections in the nervous system. Nat Rev Immunol 11:318-329
27. Kristensson K (2011) Microbes' roadmap to neurons. Nat Rev Neurosci 12:345-357
28. Haase AT (1986) Pathogenesis of lentivirus infections. Nature 322:130-136
29. Peluso R, Haase A, Stowring L et al (1985) A Trojan horse mechanisms for the spread of visna virus in monocytes. Virology 147:231-236
30. Muratori C, Mangino G, Affabris E, Federico M (2010) Astrocytes contacting HIV-1-infected macrophages increase the release of CCL2 in response to the HIV-1-dependent enhancement of membrane-associated TNFα in macrophages. Glia 58:1893-1904
31. Roberts TK, Buckner CM, Berman JW (2010) Leukocyte transmigration across the blood-brain barrier: perspectives on neuroAIDS. Front Biosci 15:478-536
32. Strazza M, Pirrone V, Wigdahl B, Nonnemacher MR (2011) Breaking down the barrier: the effects of HIV-1 on the blood-brain barrier. Brain Res 1399:96-115
33. Hirokawa N, Noda Y (2008) Intracellular trafficking and kinesin superfamily proteins, KIFs: structure, function and dynamics. Physiol Rev 88:1089-1118
34. Hsieh MJ, White PJ, Pouton CW (2010) Interaction of viruses with host cell molecular motors. Curr Opin Biotechnol 21:633-639
35. Salinas S, Schiavo G, Kremer EJ (2010) A hitchhiker's guide to the nervous system: the complex journey of viruses and toxins. Nat Rev Microbiol 8:645-655
36. Mori I, Nishiyama Y, Yokochi T, Kimura Y (2004) Virus-induced neuronal apoptosis as pathological and protective responses of the host. Rev Med Virol 14:209-216
37. Mori I, Nishiyama Y, Yokochi T, Kimura Y (2005) Olfactory transmission of neurotropic viruses. J Neurovirol 11:129-137
38. Kastrukoff L, Hamada T, Schumacher U et al (1982) Central nervous system infection and immune response in mice inoculated into the lip with herpes simplex virus type 1. J Neuroimmunol 2:295-305
39. Lewandowski G, Zimmerman MN, Denk LL et al (2002) Herpes simplex type 1 infects and establishes latency in the brain and trigeminal ganglia during primary infection of the lip in cotton rats and mice. Arch Virol 147:167-179
40. Bach LM (1963) Regional physiology of the central nervous system. Prog Neurol Psychiatry 18:46-106
41. Liedtke W, Opalka B, Zimmermann CW, Lignitz E (1993) Age distribution of latent herpes simplex virus 1 and varicella-zoster virus genome in human nervous tissue. J Neurol Sci 116:6-11
42. Boggian I, Buzzacaro E, Calistri A et al (2000) Asymptomatic herpes simplex type 1 virus infection of the mouse brain. J Neurovirol 6:303-313
43. Mori I, Goshima F, Ito H, Koide N, Yoshida T, Yokochi T, Kimura Y, Nishiyama Y (2005) The vomeronasal chemosensory system as a route of neuroinvasion by herpes simplex virus. Virology 334:51-58
44. Aronsson F, Robertson B, Ljunggren HG, Kristensson K (2003) Invasion and persistence of the neuroadapted influenza virus A/WSN/33 in the mouse olfactory system. Viral Immunol 16:415-423
45. Iwasaki T, Itamura S, Nishimura H et al (2004) Productive infection in the murine central nervous system with avian influenza virus A (H5N1) after intranasal inoculation. Acta Neuropathol (Berl) 108:485-492
46. Matsuda K, Park CH, Sunden Y et al (2004) The vagus nerve is one route of transneural invasion for intranasally inoculated influenza a virus in mice. Vet Pathol 41:101-107
47. Reinacher M, Bonin J, Narayan O, Scholtissek C (1983) Pathogenesis of neurovirulent influenza A virus infection in mice. Route of entry of virus into brain determines infection of different populations of cells. Lab Investig 49:686-692
48. Shinya K, Shimada A, Ito T et al (2000) Avian influenza virus intranasally inoculated infects the central nervous system of mice through the general visceral afferent nerve. Arch Virol 145:187-195
49. Rimmelzwaan GF, van Riel D, Baars M et al (2006) Influenza A virus (H5N1) infection in cats causes systemic disease with potential novel routes of virus spread within and between hosts. Am J Pathol 168:176-183
50. Takahashi M, Yamada T, Nakajima S et al (1995) The substantia nigra is a major target for neurovirulent influenza A virus. J Exp Med 181:2161-2169
51. De Regge N, Nauwynck HJ, Geenen K et al (2006) α-herpesvirus glycoprotein D interaction with sensory neurons triggers formation of varicosities that serve as virus exit sites. J Cell Biol 174:267-275
52. Diefenbach RJ, Miranda-Saksena M, Douglas MW, Cunningham AL (2008) Transport and egress of herpes simplex virus in neurons. Rev Med Virol 18:35-51
53. Baringer JR, Swoveland P (1973) Recovery of herpes-simplex virus from human trigeminal ganglions. N Engl J Med 288:648-650
54. Stevens JG, Wagner EK, Devi-Rao GB et al (1987) RNA complementary to a herpes virus alpha gene mRNA is prominent in latently infected neurons. Science 235:1056-1059
55. Henderson G, Jaber T, Carpenter D et al (2009) Identification of herpes simplex virus type 1 proteins encoded within the first 1.5 kb of the latency-associated transcript. J Neurovirol 15:439-448
56. Itzhaki RF, Lin WR, Shang D et al (1997) Herpes simplex virus type 1 in brain and risk of Alzheimer's disease. Lancet 349:241-244
57. Koelle DM, Magaret A, Warren T et al (2010) APOE genotype is associated with oral herpetic lesions but not genital or oral herpes simplex virus shedding. Sex Transm Infect 86:202-206
58. Wozniak MA, Mee AP, Itzhaki RF (2009) Herpes simplex virus type 1 DNA is located within Alzheimer's disease amyloid plaques. J Pathol 217:131-138
59. Letenneur L, Peres K, Fleuri H et al (2008) Sieropositive to herpes virus antibodies and risk of Alzheimer's disease: a population-based cohort study. Plos One 3:e3637
60. Lambert JC, Heath S, Even G et al (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 41:1094-1099
61. Porcellini E, Carbone I, Ianni M, Licastro F (2010) Alzheimer's disease gene signature says: beware of brain viral infections. Immun Ageing 7:16-20
62. MacIntyre A, Hammond CJ, Little CS et al (2002) Chlamydia pneumoniae infection alters the junctional complex proteins of human brain microvascular endothelial cells. FEMS Microbiol Lett 217:167-172
63. D'Andrea MR, Nagele RG, Wang HY, Lee DH (2002) Consistent immunohistochemical detection of intracellular beta-amyloid42 in pyramidal neurons of Alzheimer's disease entorhinal cortex. Neurosci Lett 333:163-166
64. Nochlin D, Shaw CM, Campbell LA, Kuo CC (1999) Failure to detect Chlamydia pneumoniae in brain tissues of Alzheimer's disease. Neurology 53:1888
65. Ring RH, Lyons JM (2000) Failure to detect Chlamydia pneumoniae in the late-onset Alzheimer's brain. J Clin Microbiol 38:2591-2594
66. Mahony JB, Chong S, Coombes BK et al (2000) Analytical sensitivity, reproducibility of results, and clinical performance of five PCR assays for detecting Chlamydia pneumoniae DNA in peripheral blood mononuclear cells. J Clin Microbiol 38:2622-2627
67. Little CS, Hammond CJ, MacIntyre A et al (2004) Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB/c mice. Neurobiol Aging 25:419-429
68. Hammond CJ, Hallock LR, Howanski RJ et al (2010) Immunohistological detection of Chlamydia pneumoniae in the Alzheimer's disease brain. BMC Neurosci 11:121-132
69. Gartner S (2000) HIV infection and dementia. Science 287:602-604
70. McArthur JC, McDermott MP, McClernon D et al (2004) Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviraltherapy. Arch Neurol 61:1687-1696
71. Corder EH, Robertson K, Lannfelt L et al (1998) HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy. Nat Med 4:1182-1184
72. Letendre SL, Ellis RJ, Ances BM et al (2010) Neurologic complications of HIV disease and their treatment. Top HIV Med 18:45-55
73. Heaton RK, Clifford DB, Franklin DR Jr et al (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER study. Neurology 75:2087-2096
74. Nath A, Schiess N, Venkatesan A et al (2008) Evolution of HIV dementia with HIV infection. Int Rev Psychiatry 20:25-31
75. Sacktor N, McDermott MP, Marder K et al (2002) HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol 8:136-142
76. Gannon P, Khana MZ, Kolsona DL (2011) Current understanding of HIV-associated neurocognitive disorders pathogenesis. Curr Opin Neurol 24:275-283
77. Wise HM, Foeglein A, Sun J et al (2009) A complicated message: identification of a novel PB1-related protein translated from influenza A virus segment 2 mRNA. J Virol 83:8021-8031
78. Jordon E (1927) Epidemic influenza: a survey. American Medical Association, Chicago
79. Oxford JS (2000) Influenza A pandemics of the 20th century with special reference to 1918: virology, pathology and epidemiology. Rev Med Virol 10:119-133
80. Taubenberger JK (2006) The origin and virulence of the 1918 "Spanish" influenza virus. Proc Am Philos Soc 150:86-112
81. Lo KC, Geddes JF, Daniels RS, Oxford JS (2003) Lack of detection of influenza genes in archived formalin-fixed, paraffin wax-embedded brain samples of encephalitis lethargica patients from 1916 to 1920. Virchows Arch 442:591-596
82. Ruest A, Michaud S, Deslandes S, Frost E (2003) Comparison of the Directigen flu A + B test, the QuickVue influenza test, and clinical case definition to viral culture and reverse transcription-PCR for rapid diagnosis of influenza virus infection. J Clin Microbiol 41:3487-4393
83. Maurizi CP (1985) Whywas the 1918 influenza pandemic so lethal? The possible role of a neurovirulent neuraminidase. Med Hypotheses 16:1-5
84. Poskanzer DC, Schwab RS (1963) Cohort analysis of Parkinson's syndrome. Evidence for a single etiology related to subclinical infection about 1920. J Chronic Dis 16:961-973
85. Ravenholt RT, Foege WH (1982) 1918 influenza, encephalitis lethargica, parkinsonism. Lancet 2:860-864
86. Martyn CN, Osmond C (1995) Parkinson's disease and the environment in early life. J Neurol Sci 132:201-206
87. Martyn CN (1997) Infection in childhood and neurological diseases in adult life. Br Med Bull 53:24-39
88. Toovey S, Jick SS, Meier CR (2011) Parkinson's disease or Parkinson symptoms following seasonal influenza. Influenza Other Respir Viruses 5:328-333
89. Soto C (2003) Unfolding the role of protein misfolding in neurodegenerative diseases. Nat Rev Neurosci 4:49-60
90. Glenner GG, Wong CW (1984) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120:885-890
91. Grundke-Iqbal I, Iqbal K, Tung YC et al (1986) Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A 83:4913-4917
92. Spillantini MG, Schmidt ML, Lee VM et al (1997) Alpha-synuclein in Lewy bodies. Nature 388:839-840
93. DiFiglia M, Sapp E, Chase KO et al (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277:1990-1993
94. Bruijn LI, Houseweart MK, Kato S et al (1998) Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 281:1851-1854
95. Bolton DC, McKinley MP, Prusiner SB (1982) Identification of a protein that purifies with the scrapie prion. Science 218:1309-1311
96. Arrasate M, Mitra S, Schweitzer ES et al (2004) Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431:805-810
97. Hardy JA, Higgins GA (1992) Alzheimer's disease: the amyloid cascade hypothesis. Science 256:184-185
98. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297:353-356
99. Bell RD, Zlokovic BV (2009) Neurovascular mechanisms and blood brain barrier disorder in Alzheimer's disease. Acta Neuropathol 118:103-113
100. Cribbs DH, Azizeh BY, Cotman CW, LaFerla FM (2000) Fibril formation and neurotoxicity by a herpes simplex virus glycoprotein B fragment with homology to the Alzheimer's A beta peptide. Biochemistry 39:5988-5994
101. Bearer EL (2004) Perspectives on herpes-APP interactions. Aging Cell 3:81-84
102. Satpute-Krishnan P, De Giorgis JA, Bearer EL (2003) Fast anterograde transport of herpes simplex virus: role for the amyloid precursor protein of Alzheimer disease. Aging Cell 2:305-318
103. Satpute-Krishnan P, De Giorgis JA, Conley MP et al (2006) A peptide zipcode sufficient for anterograde transport within amyloid precursor protein. Proc Natl Acad Sci U S A 103:16532-16537
104. Wozniak MA, Itzhaki RF, Shipley SJ, Dobson CB (2007) Herpes simplex virus infection causes cellular-amyloid accumulation and secretase upregulation. Neurosci Lett 429:95-100
105. Shipley SJ, Parkin ET, Ithzaki RF, Dobson CB (2005) Herpes simplex virus interferes with amyloid precursor protein processing. BMC Microbiol 5:48
106. 2+-mediated APP phosphorylation and Aβ accumulation in rat cortical neurons. Neurobiol Aging 32:2323.e13-2323.e26
107. De Chiara G, Marcocci ME, Civitelli L et al (2010) APP processing induced by herpes simplex virus type 1 (HSV-1) yields several APP fragments in human and rat neuronal cells. PLoS One 5:e13989
108. Cheng SB, Ferland P, Webster P, Bearer EL (2011) Herpes simplex virus dances with amyloid precursor protein while exiting the cell. PLoS One 6:e17966
109. Zambrano A, Solis L, Salvadores N et al (2008) Neuronal cytoskeletal dynamic modification and neurodegeneration induced by infection with herpes simplex virus type 1. J Alzheimers Dis 14:259-269
110. Wozniak MA, Frost AL, Itzhaki RF (2009) Alzheimer's disease-specific tau phosphorylation is induced by herpes simplex virus type 1. J Alzheimers Dis 16:341-350
111. Lerchundi R, Neira R, Valdivia S et al (2011) Tau cleavage at D421 by caspase-3 is induced in neurons and astrocytes infected with herpes simplex virus type 1. J Alzheimers Dis 23:513-520
112. Blasko I, Veerhuis R, Stampfer-Kountchev M et al (2000) Costimulatory effects of interferon-gamma and interleukin-1beta or tumor necrosis factor alpha on the synthesis of Abeta1-40 and Abeta1-42 by human astrocytes. Neurobiol Dis 7:682-689
113. Daily A, Nath A, Hersh LB (2006) Tat peptides inhibit neprilysin. J Neurovirol 12:153-160
114. Yamamoto M, Kiyota T, Horiba M et al (2007) Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice. Am J Pathol 170:680-692
115. Pulliam L (2009) HIV regulation of amyloid beta production. J Neuroimmune Pharmacol 4:213-217
116. Rempel HC, Pulliam L (2005) HIV-1 Tat inhibits neprilysin and elevates amyloid beta. AIDS 19:127-135
117. Lan X, Xu J, Kiyota T et al (2011) HIV-1 reduces Abeta-degrading enzymatic activities in primary human mononuclear phagocytes. J Immunol 186:6925-6932
118. Xu J, Ikezu T (2009) The comorbidity of HIV-associated neurocognitive disorders and Alzheimer's disease: a foreseeable medical challenge in post-HAART era. J Neuroimmune Pharmacol 4:200-212
119. Giunta B, Ehrhart J, Obregon DF et al (2011) Antiretroviral medications disrupt microglial phagocytosis of β-amyloid and increase its production by neurons: implications for HIV-associated neurocognitive disorders. Mol Brain 4:23
120. Patrick C, Crews L, Desplats P et al (2011) Increased CDK5 expression in HIV encephalitis contributes to neurodegeneration via tau phosphorylation and is reversed with Roscovitine. Am J Pathol 178:1646-1661
121. Giunta B, Hou H, Zhu Y et al (2009) HIV-1 Tat contributes to Alzheimer's disease-like pathology in PSAPP mice. Int J Clin Exp Pathol 2:433-443
122. Holcomb L, Gordon MN, McGowan E et al (1998) Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med 4:97-100
123. Kim BO, Liu Y, Ruan Y et al (2003) Neuropathologies in transgenic mice expressing human immunodeficiency virus type 1 tat protein under the regulation of the astrocyte-specific glial fibrillary acidic protein promoter and doxycycline. Am J Pathol 162:1693-1707
124. Boelen E, Steinbusch HW, van der Ven AJ (2007) Chlamydia pneumoniae infection of brain cells: an in vitro study. Neurobiol Aging 28:524-532
125. Miklossy J, Kis A, Radenovic A et al (2006) Beta-amyloid deposition and Alzheimer's type changes induced by Borrelia spirochetes. Neurobiol Aging 27:228-236
126. Soscia SJ, Kirby JE, Washicosky KJ et al (2010) The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide. PLoS One 5:e9505
127. Anderson JP, Walker DE, Goldstein JM et al (2006) Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease. J Biol Chem 281:29739-29752
128. Jang H, Boltz D, Sturm-Ramirez K et al (2009) Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration. Proc Natl Acad Sci U S A 106:14063-14068
129. Levine B, Mizushima N, Virgin HW (2011) Autophagy in immunity and inflammation. Nature 469:323-335
130. Todde V, Veenhuis M, van der Klei IJ (2009) Autophagy: principles and significance in health and disease. Biochim Biophys Acta 1792:3-13
131. Sir D, Ou JH (2010) Autophagy in viral replication and pathogenesis. Mol Cells 29:1-7
132. Cuervo AM, Bergamini E, Brunk UT et al (2005) Autophagy and aging: the importance of maintaining "clean" cells. Autophagy 1:13140
133. Levine B, Kroemer G (2008) Autophagy in the pathogenesis of disease. Cell 132:27-42
134. Shintani T, Klionsky DJ (2004) Autophagy in health and disease: a double-edged sword. Science 306:990-995
135. Nixon RA (2007) Autophagy, amyloidogenesis and Alzheimer disease. J Cell Sci 120:4081-4091
136. White E, Karp C, Strohecker AM et al (2010) Role of autophagy in suppression of inflammation and cancer. Curr Opin Cell Biol 22:212-217
137. Hara T, Nakamura K, Matsui M et al (2006) Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441:885-889
138. Komatsu M, Waguri S, Chiba T et al (2006) Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441:880-884
139. Martinez-Vicente M, Cuervo AM (2007) Autophagy and neurodegeneration: when the cleaning crew goes on strike. Lancet Neurol 6:352-361
140. Rubinsztein DC, Gestwicki JE, Murphy LO, Klionsky DJ (2007) Potential therapeutic applications of autophagy. Nat Rev Drug Discov 6:304-312
141. Williams A, Jahreiss L, Sarkar S et al (2006) Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications. Curr Top Dev Biol 76:89-101
142. Orvedahl A, Levine B (2008) Autophagy and viral neurovirulence. Cell Microbiol 10:1747-1756
143. Seay MD, Dinesh-Kumar SP (2005) Life after death: are autophagy genes involved in cell death and survival during plant innate immune responses? Autophagy 1:185-186
144. Talloczy Z, Virgin HW 4th, Levine B (2006) PKR-dependent autophagic degradation of herpes simplex virus type 1. Autophagy 2:24-29
145. Colombo MI (2005) Pathogens and autophagy: subverting to survive. Cell Death Differ 12(Suppl 2):1481-1483
146. Jackson WT, Giddings TH, Taylor MP et al (2005) Subversion of cellular autophagosomal machinery by RNA viruses. PLoS Biol 3:e156
147. Taylor MP, Kirkegaard K (2007) Modification of cellular autophagy protein LC3 by poliovirus. J Virol 81:12543-12553
148. Wileman T (2006) Aggresomes and autophagy generate sites for virus replication. Science 312:875-878
149. Talloczy Z, Jiang W, Virgin HWT et al (2002) Regulation of starvation and virus-induced autophagy by the eIF2alpha kinase signaling pathway. Proc Natl Acad Sci U S A 99:190-195
150. Cassady KA, Gross M, Roizman B (1998) The second site mutation in the herpes simplex virus recombinants lacking the gamma134.5 genes precludes shutoff of protein synthesis by blocking the phosphorylation of eIF-2alpha. J Virol 72:7005-7011
151. Chang RC, Suen KC, Ma CH et al (2002) Involvement of double-stranded RNAdependent protein kinase and phosphorylation of eukaryotic initiation factor-2alpha in neuronal degeneration. J Neurochem 83:1215-1225
152. Chou J, Chen JJ, GrossM RB (1995) Association of a M(r) 90,000 phosphoprotein with protein kinase PKR in cells exhibiting enhanced phosphorylation of translation initiation factor eIF-2 alpha and premature shutoff of protein synthesis after infection with gamma 134.5-mutants of herpes simplex virus 1. Proc Natl Acad Sci U S A 92:10516-10520
153. Orvedahl A, Alexander D, Tallóczy Z et al (2007) HSV-1 ICP34.5 confers neurovirulence by targeting the Beclin 1 autophagy protein. Cell Host Microbe 1:23-35
154. He B, Gross M, Roizman B (1997) The gamma(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase. Proc Natl Acad Sci U S A 94:843-848
155. Ill-Raga G, Palomer E, Wozniak MA et al (2011) Activation of PKR causes amyloid ß-peptide accumulation via de-repression of BACE1 expression. PLoS One 6:e21456
156. Santana S, Recuero M, Bullido MJ et al (2012) Herpes simplex virus type I induces the accumulation of intracellular β-amyloid in autophagic compartments and the inhibition of the non-amyloidogenic pathway in human neuroblastoma cells. Neurobiol Aging 33:430.e19-430.e33
157. Yu WH, Kumar A, Peterhoff C et al (2004) Autophagic vacuoles are enriched in amyloid precursor protein-secretase activities: implications for beta amyloid peptide over-production and localization in Alzheimer's disease. Int J Biochem Cell Biol 36:2531-2540
158. Gannagé M, Rämer PC, Münz C (2010) Targeting Beclin 1 for viral subversion of macroautophagy. Autophagy 6:166-167
159. Alirezaei M, Kiosses WB, Fox HS (2008) Decreased neuronal autophagy in HIV dementia: a mechanism of indirect neurotoxicity. Autophagy 4:963-966
160. Matarrese P, Nencioni L, Checconi P et al (2011) Pepstatin A alters host cell autophagic machinery and leads to a decrease in influenza A virus production. J Cell Physiol 226:3368-3377
161. Gannagé M, Dormann D, Albrecht R et al (2009) Matrix protein 2 of influenza A virus blocks autophagosome fusion with lysosomes. Cell Host Microbe 6:367-380
162. Zheng X, Chu F, Mirkin BL et al (2008) Role of the proteolytic hierarchy between cathepsin L, cathepsin D and caspase-3 in regulation of cellular susceptibility to apoptosis and autophagy. Biochim Biophys Acta 1783:2294-2300
163. Nencioni L, De Chiara G, Sgarbanti R et al (2009) Bcl-2 expression and p38MAPK activity in cells infected with influenza A virus: impact on virally induced apoptosis and viral replication. J Biol Chem 284:16004-16015
164. Butterfield DA, Reed T, Newman SF, Sultana R (2007) Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment. Free Radic Biol Med 43:658-677
165. Andersen JK (2004) Oxidative stress in neurodegeneration: cause or consequence? Nat Med 10(Suppl):S18-S25
166. Sultana R, Butterfield DA (2009) Oxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment. J Bioenerg Biomembr 41:441-446
167. Giasson BI, Duda JE, Murray IV et al (2000) Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science 290:985-989
168. Horiguchi T, Uryu K, Giasson BI et al (2003) Nitration of tau protein is linked to neurodegeneration in tauopathies. Am J Pathol 163:1021-1031
169. Ciriolo MR, Palamara AT, Incerpi S et al (1997) Loss of GSH, oxidative stress, and decrease of intracellular pH as sequential steps in viral infection. J Biol Chem 272:2700-2708
170. Gong G, Waris G, Tanveer R, Siddiqui A (2001) Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B. Proc Natl Acad Sci U S A 98:9599-9604
171. Kaul P, Biagioli MC, Singh I, Turner RB (2000) Rhinovirus-induced oxidative stress and interleukin-8 elaboration involves p47-phox but is independent of attachment to intercellular adhesion molecule-1 and viral replication. J Infect Dis 181:1885-1890
172. Nencioni L, Iuvara A, Aquilano K et al (2003) Influenza A virus replication is dependent on an antioxidant pathway that involves GSH and Bcl-2. FASEB J 17:758-760
173. Peterhans E (1997) Oxidants and antioxidants in viral diseases: disease mechanisms and metabolic regulation. J Nutr 127:S962-S965
174. Nucci C, Palamara AT, Ciriolo MR et al (2000) Imbalance in corneal redox state during herpes simplex virus 1-induced keratitis in rabbits. Effectiveness of exogenous glutathione supply. Exp Eye Res 70:215-220
175. Palamara AT, Perno CF, Ciriolo MR et al (1995) Evidence for antiviral activity of glutathione: in vitro inhibition of herpes simplex virus type 1 replication. Antiviral Res 27:237-253
176. Valyi-Nagy T, Dermody TS (2005) Role of oxidative damage in the pathogenesis of viral infections of the nervous system. Histol Histopathol 20:957-967
177. Kavouras JH, Prandovszky E, Valyi-Nagy K et al (2007) Herpes simplex virus type 1 infection induces oxidative stress and the release of bioactive lipid peroxidation by-products in mouse P19N neural cell cultures. J Neurovirol 13:416-425
178. Fujii S, Akaike T, Maeda H (1999) Role of nitric oxide in pathogenesis of herpes simplex virus encephalitis in rats. Virology 256:203-212
179. Valyi-Nagy T, Olson SJ, Valyi-Nagy K et al (2000) Herpes simplex virus type 1 latency in the murine nervous system is associated with oxidative damage to neurons. Virology 278:309-321
180. Tamagno E, Bardini P, Obbili A et al (2002) Oxidative stress increases expression and activity of BACE in NT2 neurons. Neurobiol Dis 10:279-288
181. Tamagno E, Parola M, Bardini P et al (2005) Beta-siteAPP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediatedby stress-activated protein kinases pathways. J Neurochem 92:628-636
182. Tamagno E, Guglielmotto M, Aragno M et al (2008) Oxidative stress activates a positive feedback between the gamma- and beta-secretase cleavages of the beta-amyloid precursor protein. J Neurochem 104:683-695
183. Ferrer I (2004) Stress kinases involved in tau phosphorylation in Alzheimer's disease, tauopathies and APP transgenic mice. Neurotox Res 6:469-475
184. Lee MS, Kao SC, Lemere CA et al (2003) APP processing is regulated by cytoplasmic phosphorylation. J Cell Biol 163:83-95
185. Yoshida H, Hastie CJ, McLauchlan H et al (2004) Phosphorylation of microtubule-associated protein tau by isoforms of c-Jun N-terminal kinase (JNK). J Neurochem 90:352-358
186. Zhu X, Raina AK, Rottkamp CA et al (2001) Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease. J Neurochem 76:435-441
187. Zhu X, Rottkamp CA, Hartzler A et al (2001) Activation of MKK6, an upstream activator of p38, in Alzheimer's disease. J Neurochem 79:311-318
188. Zachos G, Koffa M, Preston CM et al (2001) Herpes simplex virus type 1 blocks the apoptotic host cell defense mechanisms that target Bcl-2 and manipulates activation of p38 mitogen-activated protein kinase to improve viral replication. J Virol 75:2710-2728
189. Hargett D, McLean T, Bachenheimer SL (2005) Herpes simplex virus ICP27 activation of stress kinases JNK and p38. J Virol 79:8348-8360
190. Schachtele SJ, Hu S, Little MR, Lokensgard JR (2010) Herpes simplex virus induces neural oxidative damage via microglial cell Toll-like receptor-2. J Neuroinflammation 7:35
191. Buhl R, Jaffe HA, Holroyd KJ et al (1989) Systemic glutathione deficiency in symptom-free HIV-seropositive individuals. Lancet 2:1294-1298
192. Eck HP, Gmunder H, Hartmann M et al (1989) Low concentrations of acid-soluble thiol (cysteine) in the blood plasma of HIV-1-infected patients. Biol Chem Hoppe Seyler 370:101-108
193. Elbim C, Pillet S, Prevost MH et al (1999) Redox and activation status of monocytes from human immunodeficiency virus-infected patients: relationship with viral load. J Virol 73:4561-4566
194. Garaci E, Palamara AT, Ciriolo MR et al (1997) Intracellular GSH content and HIV replication in human macrophages. J Leukoc Biol 62:54-59
195. Turchan J, Pocernich CB, Gairola C et al (2003) Oxidative stress in HIV demented patients and protection ex vivo with novel antioxidants. Neurology 28:307-314
196. Butler TR, Smith KJ, Self RL et al (2011) Neurodegenerative effects of recombinant HIV-1 Tat(1-86) are associated with inhibition of microtubule formation and oxidative stress-related reductions in microtubule-associated protein-2(a, b). Neurochem Res 36:819-828
197. Kruman II, NathA MMP (1998) HIV-1 proteinTat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress. Exp Neurol 154:276-288
198. Mollace V, Salvemini D, Riley DP et al (2002) The contribution of oxidative stress in apoptosis of human-cultured astroglial cells induced by supernatants of HIV-1-infected macrophages. J Leukoc Biol 71:65-72
199. Adamson DC, Kopnisky KL, Dawson TM, Dawson VL (1999) Mechanisms and structural determinants of HIV-1 coat protein gp41-induced neurotoxicity. J Neurosci 19:64-71
200. Hori K, Burd PR, Furuke K et al (1999) Human immunodeficiency virus-1-infected macrophages inducible nitric oxide synthase and nitric oxide (NO) production astrocytes: astrocytic NO as a possible mediator of neuronaldamage in acquired immunodeficiency syndrome. J Immunol 93:1843-1850
201. Cai J, Chen Y, Seth S et al (2003) Inhibition of influenza infection by glutathione. Free Radic Biol Med 34:928-936
202. Hennet T, Peterhans E, Stocker R (1992) Alterations in antioxidant defences in lung and liver of mice infected with influenza A virus. J Gen Virol 73:39-46
203. Mileva M, Tancheva L, Bakalova R et al (2000) Effect of vitamin E on lipid peroxidation and liver monooxigenase activity in experimental influenza virus infection. Toxicol Lett 114:39-45
204. Nencioni L, Sgarbanti R, De Chiara G et al (2007) Influenza virus and redox mediated cell signaling: a complex network of virus/host interaction. New Microbiol 30:367-375
205. Sgarbanti R, Nencioni L, Amatore D et al (2011) Redox regulation of the influenza hemagglutinin maturation process: a new cell-mediated strategy for anti-influenza therapy. Antioxid Redox Signal 15:593-606
206. Yao D, Kuwajima M, Kido H (2003) Pathologic mechanisms of influenza encephalitis with an abnormal expression of inflammatory cytokines and accumulation of mini-plasmin. J Med Investig 50:1-8
207. Yamanaka G, Kawashima H, Suganami Y et al (2006) Diagnostic and predictive value of CSF d-ROM level in influenza virus-associated encephalopathy. J Neurol Sci 243:71-75
208. Martin HL, Teismann P (2009) Glutathione-a review on its role and significance in Parkinson's disease. FASEB J 23:3263-3272
209. Dröge W, Schipper HM (2007) Oxidative stress and aberrant signaling in aging and cognitive decline. Aging Cell 6:361-370
210. Nuss JE, Choksi KB, DeFord JH, Papaconstantinou J (2008) Decreased enzyme activities of chaperones PDI and BiP in aged mouse livers. Biochem Biophys Res Commun 365:355-361
211. Uehara T, Nakamura T, Yao D et al (2006) S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature 44:513-517
212. van Spronsen M, Hoogenraad CC (2010) Synapse pathology in psychiatric and neurologic disease. Curr Neurol Neurosci Rep 10:207-214
213. Südhof TC, Malenka RC (2008) Understanding synapses: past, present, and future. Neuron 60:469-476
214. Gilman CP, Mattson MP (2002) Do apoptotic mechanisms regulate synaptic plasticity and growth-cone motility? Neuromol Med 2:197-214
215. Mattson MP (2003) Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders. Neuromol Med 3:65-94
216. Everall IP, Heaton RK, Marcotte TD et al (1999) Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group. The HIV Neurobehavioral Research Center. Brain Pathol (Zurich, Switzerland) 9:209-217
217. Spencer DC, Price RW (1992) Human immunodeficiency virus and the central nervous system. Annu Rev Microbiol 46:655-693
218. Toggas SM, Masliah E, Rockenstein EM et al (1994) Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 367:188-193
219. Michaud J, Fajardo R, Charron G et al (2001) Neuropathology of NFHgp160 transgenic mice expressing HIV-1 env protein in neurons. J Neuropathol Exp Neurol 60:574-587
220. Catani MV, Corasaniti MT, Navarra M et al (2000) gp120 induces cell death in human neuroblastoma cells through the CXCR4 and CCR5 chemokine receptors. J Neurochem 74:2373-2379
221. Corasaniti MT, Melino G, Navarra M et al (1995) Death of cultured human neuroblastoma cells induced by HIV-1 gp120 is prevented by NMDA receptor antagonists and inhibitors of nitric oxide and cyclooxygenase. Neurodegeneration 4:315-321
222. Lipton SA, Sucher NJ, Kaiser PK, Dreyer EB (1991) Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron 7:111-118
223. i and the toxic actions of the HIV coat protein GP120. Eur J Neurosci 11:1167-1178
224. Geeraerts T, Deiva K, M'sika I et al (2006) Effects of SDF-1alpha and gp120IIIB on apoptotic pathways in SK-N-SH neuroblastoma cells. Neurosci Lett 399:115-120
225. Ushijima H, Ando S, Kunisada T (1993) HIV-1 gp120 and NMDA induce protein kinase C translocation differentially in rat primary neuronal cultures. J Acquir Immune Defic Syndr 6:339-343
226. Haughey NJ, Mattson MP (2002) Calcium dysregulation and neuronal apoptosis by the HIV-1 proteins Tat and gp120. J Acquir Immune Defic Syndr 31(Suppl 2):S55-S61
227. Xu H, Bae M, Tovar-Y-Romo LB et al (2011) The human immunodeficiency virus coat protein gp120 promotes forward trafficking and surface clustering of NMDA receptors in membrane microdomains. J Neurosci 31:17074-17090
228. 2+ that require function of an N-methyl-d-aspartate receptor polyamine-sensitive site. Brain Res 995:39-45
229. Song L, Nath A, Geiger JD et al (2003) Humanimmunodeficiency virus type 1 Tat protein directly activates neuronal N-methyl-d-aspartate receptors at an allosteric zinc-sensitive site. J Neurovirol 9:399-403
230. Bonavia R, Bajetto A, Barbero S et al (2001) HIV-1 Tat causes apoptotic death and calcium homeostasis alterations in rat neurons. Biochem Biophys Res Commun 288:301-308
231. Perez A, Probert AW, Wang KK, Sharmeen L (2001) Evaluation of HIV-1 Tat induced neurotoxicity in rat cortical cell culture. J Neurovirol 7:1-10
232. Aprea S, Del Valle L, Mameli G et al (2006) Tubulin-mediated binding of human immunodeficiency virus-1 Tat to the cytoskeleton causes proteasomal-dependent degradation of microtubule-associated protein 2 and neuronal damage. J Neurosci 26:4054-4062
233. Kim HJ, Martemyanov KA, Thayer SA (2008) Human immunodeficiency virus protein Tat induces synapse loss via a reversible process that is distinct from cell death. J Neurosci 28:12604-12613
234. Li ST, Matsushita M, Moriwaki A et al (2004) HIV-1 Tat inhibits long-term potentiation and attenuates spatial learning. Ann Neurol 55:362-371
235. Brask J, Chauhan A, Hill RH et al (2005) Effects on synaptic activity in cultured hippocampal neurons by influenza A viral proteins. J Neurovirol 11:395-402
236. Labetoulle M, Kucera P, Ugolini G et al (2000) Neuronal pathways for the propagation of herpes simplex virus type 1 from one retina to the other in a murine model. J Gen Virol 81:1201-1210
237. Cocchi F, Menotti L, Dubreuil P et al (2000) Cell-to-cell spread of wild-type herpes simplex virus type 1, but not of syncytial strains, is mediated by the immunoglobulin-like receptors that mediate virion entry, nectin1 (PRR1/HveC/HIgR) and nectin2 (PRR2/HveB). J Virol 74:3909-3917
238. Geraghty RJ, Krummenacher C, Cohen GH et al (1998) Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor. Science 280:1618-1620
239. Sakisaka T, Taniguchi T, Nakanishi H et al (2001) Requirement of interaction of nectin-1 alpha/HveC with afadin for efficient cell-cell spread of herpes simplex virus type 1. J Virol 75:4734-4743
240. Warner MS, Geraghty RJ, Martinez WM et al (1998) A cell surface protein with herpesvirus entry activity (HveB) confers susceptibility to infection by mutants of herpes simplex virus type 1, herpes simplex virus type 2 and pseudorabies virus. Virology 246:179-189
241. Mizoguchi A, Nakanishi H, Kimura K et al (2002) Nectin: an adhesion molecule involved in formation of synapses. J Cell Biol 156:555-565
242. Assunção Guimarães C, Linden R (2004) Programmed cell deaths. Apoptosis and alternative death styles. Eur J Biochem 271:1638-1650
243. DeBiasi RL, Kleinschmidt-DeMasters BK, Richardson-Burns S, Tyler KL (2002) Central nervous system apoptosis in human herpes simplex virus and cytomegalovirus encephalitis. J Infect Dis 186:1547-1557
244. Armien AG, Hu S, Little MR et al (2009) Chronic cortical and subcortical pathology with associated neurological deficits ensuing experimental herpes encephalitis. Brain Pathol 20:738-750
245. Perkins D, Gyure KA, Pereira F, Aurelian L (2003) Herpes simplex virus type 1-induced encephalitis has an apoptotic component associated with activation of c-Jun N-terminal kinase. J Neurovirol 9:101-111
246. Perng GC, Jones C, Ciacci-Zanella J et al (2000) Virus induced neuronal apoptosis blocked by the herpes simplex virus latency associated transcript (LAT). Science 287:1500-1503
247. Henderson G, Perng GC, Nesburn AB et al (2004) The latency-related gene encoded by bovine herpesvirus 1 can suppress caspase 3 and caspase 9 cleavage during productive infection. J Neurovirol 10:64-70
248. Jin L, Peng W, Perng GC et al (2003) Identification of herpes simplex virus type 1 latency associated transcript sequences that both inhibit apoptosis and enhance the spontaneous reactivation phenotype. J Virol 77:6556-6561
249. Peng W, Jin L, Henderson G et al (2004) Mapping herpes simplex virus type 1 latency-associated transcript sequences that protect from apoptosis mediated by a plasmid expressing caspase-8. J Neurovirol 10:260-265
250. Jiang X, Chentoufi AA, Hsiang C et al (2011) The herpes simplex virus type 1 latency-associated transcript can protect neuron-derived C1300 and Neuro2A cells from granzyme B-induced apoptosis and CD8 T-cell killing. J Virol 85:2325-2332
251. Li S, Carpenter D, Hsiang C et al (2010) Herpes simplex virus type 1 latency-associated transcript inhibits apoptosis and promotes neurite sprouting in neuroblastoma cells following serum starvation by maintaining protein kinase B (AKT) levels. J Gen Virol 91:858-866
252. Leib DA, Bogard CL, Kosz-Vnenchak M et al (1989) A deletion mutant of the latency-associated transcript of herpes simplex virus type 1 reactivates from the latent state with reduced frequency. J Virol 63:2893-2900
253. Perng GC, Dunkel EC, Geary PA et al (1994) The latency-associated transcript gene of herpes simplex virus type 1 (HSV-1) is required for efficient in vivo spontaneous reactivation of HSV-1 from latency. J Virol 68:8045-8055
254. Trousdale MD, Steiner I, Spivack JG et al (1991) In vivo and in vitro reactivation impairment of a herpes simplex virus type 1 latency-associated transcript variant in a rabbit eye model. J Virol 65:6989-6993
255. Asano S, Honda T, Goshima F et al (1999) US3 protein kinase of herpes simplex virus type 2 plays a role in protecting corneal epithelial cells from apoptosis in infected mice. J Gen Virol 80:51-56
256. Aubert M, Blaho JA (1999) The herpes simplex virus type 1 regulatory protein ICP27 is required for the prevention of apoptosis in infected human cells. J Virol 73:2803-2813
257. Galvan V, Roizman B (1998) Herpes simplex virus 1 induces and blocks apoptosis at multiple steps during infection and protects cells from exogenous inducers in a cell-type dependent manner. Proc Natl Acad Sci U S A 95:3931-3936
258. Galvan V, Brandimarti R, Roizman B (1999) Herpes simplex virus 1 blocks caspase-3-independent and caspasedependent pathways to cell death. J Virol 73:3219-3226
259. Leopardi R, Roizman B (1996) The herpes simplex virus major regulatory protein ICP4 blocks apoptosis induced by the virus or by hyperthermia. Proc Natl Acad Sci U S A 93:9583-9587
260. Gautier I, Coppey J, Durieux C (2003) Early apoptosis-related changes triggered by HSV-1 in individual neuronlike cells. Exp Cell Res 289:174-183
261. Zhou G, Galvan V, Campadelli-Fiume G, Roizman B (2000) Glycoprotein D or J delivered in trans blocks apoptosis in SK-N-SH cells induced by a herpes simplex virus 1 mutant lacking intact genes expressing both glycoproteins. J Virol 74:11782-11791
262. Perkins D, Pereira EF, Gober M et al (2002) The herpes simplex virus type 2 R1 protein kinase (ICP10 PK) blocks apoptosis in hippocampal neurons, involving activation of the MEK/MAPK survival pathway. J Virol 76:1435-1449
263. Perkins D, Pereira EF, Aurelian L (2003) The herpes simplex virus type 2 R1 protein kinase (ICP10 PK) functions as a dominant regulator of apoptosis in hippocampal neurons involving activation of the ERK survival pathway and upregulation of the antiapoptotic protein Bag-1. J Virol 77:1292-1305
264. Carter CJ (2011) Alzheimer's disease plaques and tangles: cemeteries of a pyrrhic victory of the immune defence network against herpes simplex infection at the expense of complement and inflammation-mediated neuronal destruction. Neurochem Int 58:301-320
265. Honjo K, van Reekum R, Verhoeff NP (2009) Alzheimer's disease and infection: do infectious agents contribute to progression of Alzheimer's disease? Alzheimers Dement 5:348-360
266. Conrady CD, Drevets DA, Carr DJ (2010) Herpes simplex type I (HSV-1) infection of the nervous system: is an immune response a good thing? J Neuroimmunol 220:1-9
267. van Zandbergen G, Gieffers J, Kothe H et al (2004) Chlamydia pneumoniae multiply in neutrophil granulocytes and delay their spontaneous apoptosis. J Immunol 172:1768-1776
268. Airenne S, Surcel HM, Tuukkanen J (2002) Chlamydia pneumoniae inhibits apoptosis in human epithelial and monocyte cell lines. Scand J Immunol 55:390-398
269. Carratelli CR, Rizzo A, Catania MR et al (2002) Chlamydia pneumoniae infections prevent the programmed cell death on THP-1 cell line. FEMS Microbiol Lett 215:69-74
270. Paland N, Rajalingam K, Machuy N et al (2006) NF-kappaB and inhibitor of apoptosis proteins are required for apoptosis resistance of epithelial cells persistently infected with chlamydophila pneumoniae. Cell Microbiol 8:1643-1655
271. Rajalingam K, Al-Younes H, Muller A et al (2001) Epithelial cells infected with chlamydophila pneumonia. Infect Immun 69:7880-7888
272. Appelt DM, Roupas MR, Way DS et al (2008) Inhibition of apoptosis in neuronal cells infected with Chlamydophila (Chlamydia) pneumoniae. BMC Neurosci 9:13
273. Gerard HC, Wildt KL, Whittum-Hudson JA et al (2005) The load of Chlamydia pneumoniae in the alzheimer's brain varies with APOE genotype. Microb Pathog 39:19-26
274. Gerard HC, Dreses-Werringloer U, Wildt KS et al (2006) Chlamydophila (chlamydia) pneumoniae in the alzheimer's brain. FEMS Immunol Med Microbiol 48:355-366
275. Nazzal D, Cantero AV, Therville N et al (2006) Chlamydia pneumoniae alters mildly oxidized low-density lipoprotein-induced cell death in human endothelial cells, leading to necrosis rather than apoptosis. J Infect Dis 193:136-145
276. Everall IP, Luthert PJ, Lantos PL (1991) Neuronal loss in the frontal cortex in HIV infection. Lancet 337:1119-1121
277. Jones G, Power C (2006) Regulation of neural cell survival by HIV-1 infection. Neurobiol Dis 21:1-17
278. Ketzler S, Weis S, Haug H, Budka H (1990) Loss of neurons in the frontal cortex in AIDS brains. Acta Neuropathol 80:92-94
279. Petito CK, Roberts B (1995) Evidence of apoptotic cell death in HIV encephalitis. Am J Pathol 146:1121-1130
280. Yoshioka M, Bradley WG, Shapshak et al (1995) Role of immune activation and cytokine expression in HIV-1-associated neurologic diseases. Adv Neuroimmunol 5:335-358
281. Corasaniti MT, Nistico R, Costa A et al (2001) The HIV-1 envelope protein, gp120, causes neuronal apoptosis in the neocortex of the adult rat: a useful experimental model to study neuroaids. Funct Neurol 16:31-38
282. Oh JW, Drabik K, Kutsch O et al (2001) CXC chemokine receptor 4 expression and function in human astroglioma cells. J Immunol 166:2695-2704
283. Hesselgesser J, Taub D, Baskar P et al (1998) Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1 alpha is mediated by the chemokine receptor CXCR4. Curr Biol 8:595-598
284. Zheng J, Thylin MR, Ghorpade A et al (1999) Intracellular CXCR4 signaling, neuronal apoptosis and neuropathogenic mechanisms of HIV-1-associated dementia. J Neuroimmunol 98:185-200
285. Brenneman DE, Westbrook GL, Fitzgerald SP (1988) Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature 335:639-642
286. Lannuzel A, Barnier JV, Hery C et al (1997) Human immunodeficiency virus type 1 and its coat protein gp120 induce apoptosis and activate JNK and ERK mitogen-activated protein kinases in human neurons. Ann Neurol 42:847-856
287. Meucci O, Miller RJ (1996) gp120-induced neurotoxicity in hippocampal pyramidal neuron cultures: protective action of TGF-beta1. J Neurosci 16:4080-4088
288. Müller WE, Schröder HC, Ushijima H et al (1992) gp120 of HIV-1 induces apoptosis in rat cortical cell cultures: prevention by memantine. Eur J Pharmacol 226:209-214
289. Acquas E, Bachis A, Nosheny RL et al (2004) Human immunodeficiency virus type 1 protein gp120 causes neuronal cell death in the rat brain by activating caspases. Neurotox Res 5:605-615
290. Bagetta G, Corasaniti MT, Berliocchi L et al (1995) HIV-1 gp120 produces DNA fragmentation in the cerebral cortex of rat. Biochem Biophys Res Commun 211:130-136
291. Bagetta G, Corasaniti MT, Malorni W et al (1996) The HIV-1 gp120 causes ultrastructural changes typical of apoptosis in the rat cerebral cortex. Neuroreport 7:1722-1724
292. Ramirez SH, Sanchez JF, Dimitri CA et al (2001) Neurotrophins prevent HIV Tat-induced neuronal apoptosis via a nuclear factor-kappaB (NF-kappaB)- dependent mechanism. J Neurochem 78:874-889
293. Zauli G, Milani D, Mirandola P et al (2001) HIV-1 Tat protein down-regulates CREB transcription factor expression in PC12 neuronal cells through a phosphatidylinositol 3-kinase/ AKT/cyclic nucleoside phosphodiesterase pathway. FASEB J 15:483-491
294. Ferrucci A, Nonnemacher MR, Wigdahl B (2011) Human immunodeficiency virus viral protein R as an extracellular protein in neuropathogenesis. Adv Virus Res 81:165-199
295. Piller SC, Jans P, Gage PW, Jans DA (1998) Extracellular HIV-1 virus protein R causes a large inward current and cell death in cultured hippocampal neurons: implications for AIDS pathology. Proc Natl Acad Sci U S A 95:4595-4600
296. Patel CA, Mukhtar M, Pomerantz RJ (2000) HIV-1 Vpr induces apoptosis in human neuronal cells. J Virol 74:9717-9726
297. Kaul M, Lipton SA (1999) Chemokines and activated macrophages in HIV gp120-induced neronal apoptosis. Proc Natl Acad Sci U S A 96:8212-8216
298. Garden GA (2002) Microglia in human immunodeficiency virus-associated neurodegeneration. Glia 40:240-251
299. Zhang K, McQuibban GA, Silva C et al (2003) HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration. Nat Neurosci 6:1064-1071
300. Zhang Z, Zhang J, Huang K et al (2009) Systemic infection of avian influenza A virus H5N1 subtype in humans. Hum Pathol 40:735-739
301. Gu J, Xie Z, Gao Z, Liu J et al (2007) H5N1 infection of the respiratory tract and beyond: a molecular pathology study. Lancet 370:1137-1145
302. Ng YP, Lee SM, Cheung TK et al (2010) Avian influenza H5N1 virus induces cytopathy and proinflammatory cytokine responses in human astrocytic and neuronal cell lines. Neuroscience 168:613-623
303. Rohn TT, Catlin LW (2011) Immunolocalization of influenza A virus and markers of inflammation in the human Parkinson's disease brain. PLoS One 6:e20495
304. Nakai Y, Itoh M, Mizuguchi M et al (2003) Apoptosis and microglial activation in influenza encephalopathy. Acta Neuropathol 105:233-239